Monitoring of residual heparinisation after cardiac surgery with thromboelastography (TEG) and postoperative bloodloss

Recruiting

• Conditions: residual blood anticoagulation; residual heparinisation; 10064477

• Registration Number: NL-OMON43335
• Lead Sponsor: Sint Antonius Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

>18 years
mentally competent
elective CABG and (multiple) heart valve surgery or multiple heart valve surgery alone
signed informed consent

Exclusion Criteria

congenital or acquired coagulation disorder
cardiac re-operation within 1 year
pregnancy
INR > 1.8

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary goal of this reasearch is to determine to which extent residual<br /><br>heparinisation is correlated with post-operative blood loss after elective<br /><br>cardiac surgery.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome of this reasearch is to determine to which extent TEG and ACT<br /><br>can predict post-operative blood loss and to which extent residual<br /><br>heparinisation is associated with thrombocyte dysfunction.</p><br>